Article

SARS-Cov-2 Infection versus Vaccine-Induced Immunity among Veterans

2021-09-29

Abstract excerpt

<h4>Background</h4> With over 40 million cases of SARS-CoV-2 infection reported in the US and discussion of both vaccine mandates as well as boosters ongoing, we aim to examine protection conferred by previous infection compared with vaccination so that citizens and policy makers can make informed decisions. <h4>Objectives</h4> To compare mRNA COVID-19 vaccine-induced immunity against immunity induced by previous...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2fa8f0db-4f14-5539-be4e-8c0d1252d524
DOI: 10.1101/2021.09.27.21264194

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-Cov-2 Infection versus Vaccine-Induced Immunity among VeteransDOI 10.1101/2021.09.27.21264194Read

Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infectionsSemantic proximity Read

Risk of SARS-CoV-2 Infection and Hospitalization in Individuals with Natural, Vaccine-Induced and Hybrid Immunity: A Retrospective Nationwide Study from EstoniaSemantic proximity Read

Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United StatesSemantic proximity Read

National- and state-level SARS-CoV-2 immunity trends from January 2020 to December 2023: a mathematical modeling analysisSemantic proximity Read

Effectiveness of Covid-19 vaccines against symptomatic and asymptomatic SARS-CoV-2 infections in an urgent care settingSemantic proximity Read

Protection afforded by post-infection SARS-CoV-2 vaccine doses: a cohort study in ShanghaiSemantic proximity Read

Deaths averted by vaccination due to reduced transmission can exceed those from direct protection of vaccinated individuals for SARS-CoV-2Semantic proximity Read

An immune correlate of SARS-CoV-2 infection and severity of reinfectionsSemantic proximity Read

Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha (B.1.1.7), Delta (B.1.617.2) or Omicron (B.1.1.529) dominance: A Danish nationwide studySemantic proximity Read

Increased risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individualsSemantic proximity Read

Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022Semantic proximity Read

Expert Review of Global Real-World Vaccine Effectiveness Against SARS-CoV-2Semantic proximity Read